查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1504940

癌症恶病质市场、占有率、规模、趋势、产业分析报告：按疗法、作用机制、通路、地区、细分市场预测，2024-2032年

Cancer Cachexia Market Share, Size, Trends, Industry Analysis Report, By Therapeutics (Progestogens, Corticosteroids, Combination Therapy, and Others); By Mechanism of Action; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到2032年，全球癌症恶病质市场规模预计将达到 34.3 亿美元。本报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

癌症盛行率的急剧增加，尤其是在老年族群中，以及医疗保健专业人员对恶病质重要性的认识不断提高，都有助于全球市场的成长。随着癌症患者数量的增加，个体罹患癌症恶病质的风险也随之增加。

例如，根据 GLOBOCAN2022 资料，到2022年，超过 53%的癌症患者年龄将超过 65 岁。随着世界老化人口迅速增加，预计到2022年将增加到 7.6 亿，到2050年将增加到 16 亿，癌症的盛行率也可能很高。

越来越多的政府措施支持癌症研究并促进先进治疗和药物的市场发展也支持了市场成长。有一些大型製药公司参与开发专门用于解决癌症恶病质的新疗法。

例如，2023年 8月，Actimed Therapeutics 宣布筹集了 475 万英镑，用于治疗癌症恶病质和许多其他肌肉萎缩疾病。这笔资金将用于继续公司的发展并确保其 IMPACT 临床开发计划做好准备。

癌症是40岁至79岁族群的第一大死因，80%的癌症患者与恶病质有关，约20%的患者死于癌症恶病质。非常需要对这种复杂的病症进行进一步研究，并开发针对与恶病质相关的特定分子途径的标靶治疗。

例如，2023年9月，Actimed Therapeutics宣布其S-pindolol Benzate（一种治疗非小细胞肺癌患者恶病质的药物）的2B/3期临床试验IND申请已获得FDA批准美国FDA。

癌症恶病质市场报告亮点

2023年，黄体素药物因其高治疗效率和抗发炎作用而占有显着占有率。

食慾刺激剂细分市场在2023年占据了大部分占有率，这归因于癌症患者广泛采用来保持体形和体质。

由于线上药局具有处方管理和节省时间等功能，因此越来越受欢迎，被归类为通路的线上药局细分市场预计在预测期内将以最高的年复合成长率成长。

北美因其完善的医疗基础设施和高癌症盛行率而在全球市场占据主导地位。

主要市场参与者包括 Aeterna Zentaris、ANI Pharmaceuticals、Merck &Co.Inc.、TCI Peptide Therapeutics 和 Teva Pharmaceutical Industries。

目录

第1章 简介

  • 报告摘要
    • 研究目的
    • 市场范围
    • 先决条件
  • 利害关係人

第2章 执行摘要

第3章 研究方法

第4章 全球癌症恶病质市场洞察

  • 分销通路快照
  • 癌症恶病质市场动态
    • 推动因素和机会
      • 癌症恶病质盛行率的增加推动了全球市场的成长
      • 研发活动投资的增加推动市场成长
    • 抑制因素和挑战
      • 治疗成本高、监管严格
  • PESTEL 分析
  • 癌症恶病质市场的通路趋势
  • 价值链分析
  • 新冠肺炎（COVID-19）影响分析

第5章 全球癌症恶病质市场：依治疗分类

  • 主要发现
  • 简介
  • 黄体素
  • 皮质类固醇
  • 合併治疗
  • 其他

第6章 全球癌症恶病质市场：依作用机制

  • 主要发现
  • 简介
  • 食慾刺激剂
  • 体重稳定剂

第7章 全球癌症恶病质市场：依通路划分

  • 主要发现
  • 简介
  • 医院药房
  • 零售药局
  • 网路药局

第8章 全球癌症恶病质市场：依地区

  • 主要发现
  • 简介
    • 癌症恶病质市场评估：依地区划分，2019-2032年
  • 北美
    • 北美：依治疗分类，2019-2032年
    • 北美：依通路划分，2019-2032年
    • 北美：依作用机制划分，2019-2032年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依疗法分类，2019-2032年
    • 欧洲：依通路划分，2019-2032年
    • 欧洲：依作用机制划分，2019-2032年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 亚太地区：依疗法分类，2019-2032年
    • 亚太地区：依通路划分，2019-2032年
    • 亚太地区：依作用机制划分，2019-2032年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
  • 中东、非洲
    • 中东和非洲：依疗法分类，2019-2032年
    • 中东与非洲：依通路划分，2019-2032年
    • 中东与非洲：依作用机制划分，2019-2032年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依疗法分类，2019-2032年
    • 拉丁美洲：依通路划分，2019-2032年
    • 拉丁美洲：依作用机制划分，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 竞争态势

  • 扩张与收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/揭露

第10章 公司简介

  • AbbVie Inc.（US）
  • Actimed Therapeutics（UK）
  • Aeterna Zentaris Inc.（Canada）
  • ANI Pharmaceuticals Inc.（US）
  • Aphios Corporation（US）
  • Aveo Pharmaceuticals Inc.（US）
  • Bristol-Myers Squibb Company（US）
  • Helsinn Group（Switzerland）
  • Hikma Pharmaceuticals PLC（UK）
  • Merck & Co. Inc.（US）
  • Mylan N.V.（US）
  • Pfizer Inc.（US）
  • TCI Peptide Therapeutics（US）
  • Teva Pharmaceutical Industries Ltd.（Israel）
Product Code: PM4913

The global cancer cachexia market size is expected to reach USD 3.43 billion by 2032, according to a new study by Polaris Market Research. The report "Cancer Cachexia Market Share, Size, Trends, Industry Analysis Report, By Therapeutics (Progestogens, Corticosteroids, Combination Therapy, and Others); By Mechanism of Action; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The drastic increase in the prevalence of cancer, especially among the geriatric population, and growing awareness among healthcare professionals about the significance of cachexia contribute to the global market growth. With the increase in cancer patients, the risk of developing cancer cachexia among individuals also rises.

For instance, according to the GLOBOCAN 2022 data, more than 53% of people who had cancer in 2022 were aged 65 years or above. As the world's ageing population is growing rapidly, with 760 million people in 2022, and is expected to rise to 1.6 billion people by 2050, the prevalence of cancer is also likely to increase.

A growing number of government initiatives supporting cancer research and promoting the development of advanced therapies and drugs also propelled the market's growth. There are key pharmaceutical companies involved in the development of new novel therapies that are specifically developed for addressing cancer cachexia.

For instance, in August 2023, Actimed Therapeutics, announced that they have raised £4.75 million for the treatment of cancer cachexia and many other muscle wasting disorders. The fund will be utilized to continue the development of the company and ensure the preparation of the IMPACT clinical development program.

Cancer remains the leading cause of death for people between the ages of 40-79 years old, and 80% of cancer cases are associated with cachexia, and approx. 20% of patients die due to cancer cachexia; there is a significant need for further studies regarding its complex condition and the development of targeted therapies that are aimed at the specific molecular pathways associated with cachexia.

For instance, in September 2023, Actimed Therapeutics, announced that they have received approval from US FDA for their IND application for Phase 2b/3 clinical study of the S-pindolol benzoate for the treatment of cachexia that are associated with patients with non-small cell lung cancer.

Cancer Cachexia Market Report Highlights

The Progestogens segment accounted for a notable share in 2023, on account of its greater efficiency in treatment and the presence of anti-inflammatory properties.

Appetite stimulators segment held the majority share in 2023, which is attributed to its widespread adoption by cancer patients for maintaining body shape and mass.

The online pharmacy segment categorized under the distribution channel is predicted to grow at the highest CAGR during the forecast period due to the growing popularity of online pharmacies due to its features like prescription management and time-saving.

North America dominated the global market, owing to the presence of well-established healthcare infrastructure and the significant prevalence of cancer.

The key market players include Aeterna Zentaris, ANI Pharmaceuticals, Merck & Co. Inc., TCI Peptide Therapeutics, and Teva Pharmaceutical Industries.

Polaris Market Research has segmented the cancer cachexia market report based on therapeutics, mechanism of action, distribution channel, and region:

Cancer Cachexia, Therapeutics Outlook (Revenue - USD Billion, 2024 - 2032)

  • Progestogens
  • Corticosteroids
  • Combination Therapy
  • Others

Cancer Cachexia, Mechanism of Action Outlook (Revenue - USD Billion, 2024 - 2032)

  • Appetite Stimulators
  • Weight Loss Stabilizers

Cancer Cachexia, Distribution Channel Outlook (Revenue - USD Billion, 2024 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Cancer Cachexia, Regional Outlook (Revenue - USD Billion, 2024 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East and Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cancer Cachexia Market Insights

  • 4.1. Cancer Cachexia Market - Distribution Channel Snapshot
  • 4.2. Cancer Cachexia Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of cancer cachexia cases to drive global market growth
      • 4.2.1.2. Rising investments in R&D activities spurring market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High treatment costs and stringent regulations
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cancer Cachexia Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cancer Cachexia Market, by Therapeutics

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • 5.3. Progestogens
    • 5.3.1. Global Cancer Cachexia Market, by Progestogens, by Region, 2019-2032 (USD Billion)
  • 5.4. Corticosteroids
    • 5.4.1. Global Cancer Cachexia Market, by Corticosteroids, by Region, 2019-2032 (USD Billion)
  • 5.5. Combination Therapy
    • 5.5.1. Global Cancer Cachexia Market, by Combination Therapy, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Cancer Cachexia Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Cancer Cachexia Market, by Mechanism of Action

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • 6.3. Appetite Stimulators
    • 6.3.1. Global Cancer Cachexia Market, by Appetite Stimulators, by Region, 2019-2032 (USD Billion)
  • 6.4. Weight Loss Stabilizers
    • 6.4.1. Global Cancer Cachexia Market, by Weight Loss Stabilizers, by Region, 2019-2032 (USD Billion)

7. Global Cancer Cachexia Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Cancer Cachexia Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Retail Pharmacy
    • 7.4.1. Global Cancer Cachexia Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Global Cancer Cachexia Market, by Online Pharmacy, By Region, 2019-2032 (USD Billion)

8. Global Cancer Cachexia Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cancer Cachexia Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Cancer Cachexia Market - North America
    • 8.3.1. North America: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
    • 8.3.2. North America: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.3. North America: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.3.4. Cancer Cachexia Market - U.S.
      • 8.3.4.1. U.S.: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.3.5. Cancer Cachexia Market - Canada
      • 8.3.5.1. Canada: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • 8.4. Cancer Cachexia Market - Europe
    • 8.4.1. Europe: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.4. Cancer Cachexia Market - UK
      • 8.4.4.1. UK: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.5. Cancer Cachexia Market - France
      • 8.4.5.1. France: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.6. Cancer Cachexia Market - Germany
      • 8.4.6.1. Germany: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.7. Cancer Cachexia Market - Italy
      • 8.4.7.1. Italy: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.8. Cancer Cachexia Market - Spain
      • 8.4.8.1. Spain: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.9. Cancer Cachexia Market - Netherlands
      • 8.4.9.1. Netherlands: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.4.10. Cancer Cachexia Market - Russia
      • 8.4.10.1. Russia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • 8.5. Cancer Cachexia Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.5.4. Cancer Cachexia Market - China
      • 8.5.4.1. China: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.5.5. Cancer Cachexia Market - India
      • 8.5.5.1. India: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.5.6. Cancer Cachexia Market - Malaysia
      • 8.5.6.1. Malaysia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.5.7. Cancer Cachexia Market - Japan
      • 8.5.7.1. Japan: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.5.8. Cancer Cachexia Market - Indonesia
      • 8.5.8.1. Indonesia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.5.9. Cancer Cachexia Market - South Korea
      • 8.5.9.1. South Korea: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • 8.6. Cancer Cachexia Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.6.4. Cancer Cachexia Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.6.5. Cancer Cachexia Market - UAE
      • 8.6.5.1. UAE: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.6.6. Cancer Cachexia Market - Israel
      • 8.6.6.1. Israel: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.6.7. Cancer Cachexia Market - South Africa
      • 8.6.7.1. South Africa: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • 8.7. Cancer Cachexia Market - Latin America
    • 8.7.1. Latin America: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.7.4. Cancer Cachexia Market - Mexico
      • 8.7.4.1. Mexico: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.7.5. Cancer Cachexia Market - Brazil
      • 8.7.5.1. Brazil: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
    • 8.7.6. Cancer Cachexia Market - Argentina
      • 8.7.6.1. Argentina: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc. (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Actimed Therapeutics (UK)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3.Aeterna Zentaris Inc. (Canada)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. ANI Pharmaceuticals Inc. (US)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Aphios Corporation (US)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Aveo Pharmaceuticals Inc. (US)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Bristol-Myers Squibb Company (US)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Helsinn Group (Switzerland)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Hikma Pharmaceuticals PLC (UK)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Merck & Co. Inc. (US)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Mylan N.V. (US)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Pfizer Inc. (US)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. TCI Peptide Therapeutics (US)
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Teva Pharmaceutical Industries Ltd. (Israel)
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development

List of Tables

  • Table 1 Global Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 2 Global Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 3 Global Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 4 Cancer Cachexia Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 6 North America: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 7 North America: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 8 U.S.: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 9 U.S.: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 10 U.S.: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Canada: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 12 Canada: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 13 Canada: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Europe: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 15 Europe: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 16 Europe: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 UK: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 18 UK: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 19 UK: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 France: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 21 France: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 22 France: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Germany: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 24 Germany: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 25 Germany: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Italy: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 27 Italy: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 28 Italy: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 Spain: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 30 Spain: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 31 Spain: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Russia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 36 Russia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 37 Russia: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 China: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 42 China: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 43 China: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 44 India: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 45 India: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 46 India: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Japan: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 51 Japan: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 52 Japan: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 South Korea: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 57 South Korea: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 58 South Korea: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 UAE: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 66 UAE: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 67 UAE: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 68 Israel: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 69 Israel: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 70 Israel: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 South Africa: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 72 South Africa: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 73 South Africa: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 Latin America: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 75 Latin America: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 76 Latin America: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 77 Mexico: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 78 Mexico: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 79 Mexico: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 Brazil: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 81 Brazil: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 82 Brazil: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 83 Argentina: Cancer Cachexia Market, by Therapeutics, 2019-2032 (USD Billion)
  • Table 84 Argentina: Cancer Cachexia Market, by Mechanism of Action, 2019-2032 (USD Billion)
  • Table 85 Argentina: Cancer Cachexia Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cancer Cachexia Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Mechanism of Action
  • Figure 7. Global Cancer Cachexia Market, by Mechanism of Action, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Therapeutics
  • Figure 9. Global Cancer Cachexia Market, by Therapeutics, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Cancer Cachexia Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 12. Cancer Cachexia Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Cancer Cachexia Market